Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that activates appetite-control centers in the brain to produce sustained weight loss
Semaglutide from licensed 503A compounding pharmacies undergoes rigorous quality testing and potency verification, ensuring consistent purity and safety comparable to brand medications
However, intraorally, hyperpigmentation is more typically a consequence of physiologic, idiopathic sources, neoplasia, medications, high serum concentrations of pituitary adrenocorticotropic hormone (ACTH), postinflammatory changes, and genetic or autoimmune disorders
Quantification of absorbance of the blots was performed using densitometric scanning with a Fusion-FX7 system (Vilber Lourmat, Collgien, France) with mean optical density of the samples normalized to that of GAPDH
Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells: modulation of EGF-induced trafficking and signaling